HemaSphere (Jun 2022)

P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA

  • A. Bazinet,
  • E. Jabbour,
  • H. Kantarjian,
  • K. Chien,
  • C. DiNardo,
  • M. Ohanian,
  • N. Daver,
  • R. Kanagal-Shamanna,
  • T. Kadia,
  • K. Takahashi,
  • L. Masarova,
  • N. Short,
  • Y. Alvarado,
  • P. Thompson,
  • G. Montalban-Bravo,
  • M. Yilmaz,
  • F. Ravandi,
  • M. Konopleva,
  • M. Andreeff,
  • S. Kornblau,
  • N. Pemmaraju,
  • D. Hammond,
  • H. Schneider,
  • B. Mirabella,
  • G. Garcia-Manero

DOI
https://doi.org/10.1097/01.HS9.0000845912.50259.67
Journal volume & issue
Vol. 6
pp. 652 – 653

Abstract

Read online

No abstracts available.